Innate Pharma (IPH.PA ): R&D Update On April 10, 2014 In New York
3/17/2014 9:05:10 AM
MARSEILLE, France, March 17, 2014 (GLOBE NEWSWIRE) -- Innate Pharma SA (the "Company" - Euronext Paris: FR0010331421 - IPH), the innate immunity company developing first-in-class drugs for cancer and inflammatory diseases, today announces that the Company will host a Research and Development Update on April 10, 2014, in New York, from 8am to 1pm.
Help employers find you! Check out all the jobs and post your resume.
comments powered by